11791020 Gateway® LR Clonase® II ...

Gateway® LR Clonase® II  现货Invitrogen

  / 4000-520-616/

Gateway® LR Clonase® II  现货Invitrogen

Gateway® LR Clonase® II  现货Invitrogen

描述

The Baculovirus Expression System with Gateway® Technology is designed to create recombinant pFastBac™ plasmids containing the polyhedrin promoter. The Baculovirus Expression System with Gateway® Technology offers:

• Expression using the Bac-to-Bac® technology (1)
• Destination vectors carrying the polyhedrin promoter for production of native (pDEST™8), N-terminal histidine fusion (pDEST™10), and N-terminal GST fusion (pDEST™20) proteins
• pDEST™10 vector containing a TEV protease cleavage site for removal of the fusion tag after protein purification (2)

Gateway® LR Clonase® II 酶混合物催化入门载体（含有侧翼是 attL 位点的目的基因）与目的载体（含有 attR 位点）进行体外重组，产生表达克隆。 Gateway® LR Clonase® II 为包含酶和缓冲剂的单一混合物，所需的移液步骤更少，因此便于设置十微升反应体系。

The Baculovirus Expression System with Gateway® Technology is designed to create recombinant pFastBac™ plasmids containing the polyhedrin promoter. The Baculovirus Expression System with Gateway® Technology offers:

Gateway® LR Clonase® II  现货Invitrogen

The Baculovirus Expression System with Gateway® Technology is designed to create recombinant pFastBac™ plasmids containing the polyhedrin promoter. The Baculovirus Expression System with Gateway® Technology offers:

Gateway® LR Clonase® II  现货Invitrogen

Invitrogen品Pai创立于1987年，品Pai承诺是帮助研究者更快、更好地进行生命科学实验。从那时起，这个品Pai就凝聚了一些具有同样品Pai承诺的ling先企业。今天，我们用一个词来诠释我们的品Pai承诺：加速。Invitrogen的目标是加速对生物学的理解，用科学改善人类的生活。“加速”是我们的核心追求和公司的核心特质。Invitrogen的产品和服务能够为世界70多个国家的学术和政府研究机构以及制药和生物技术公司提供支持，帮助它们进一步改善人类的生活状况。Invitrogen品Pai结合了由科学界的所设计的技术、产品和服务，用来加速所有领域的研究，包括基因体功能分析、细胞生物学、药品开发和商业生物生产